Your doctor or health provider performs cervical screening to look for cervical and/or vaginal cells that are cancerous or potentially pre-cancerous. The cell suspension is tested for the presence of high-risk HPV . If HPV DNA is present, cells from the suspension are placed on a glass slide, stained with special dyes, and viewed under a microscope by a cytologist and/or pathologist. The test can also be used to detect vaginal or uterine infections. This allows infections to be treated promptly, thus avoiding further discomfort or more serious complications.
- Routine cervical screening should be carried out every five years for women who have no or history suggestive of cervical pathology
- All women who have ever been sexually active should start having cervical screening at 25 years of age, or if sexually active women of any age has abnormal vaginal symptoms
- Cervical screening tests may cease at the age of 74 years. Women over 74 years who have never had a cervical screening test, or who request a cervical screening test, should be screened.
Women with abnormal results should be managed in accordance with the NHMRC Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities. Most of the costs may be claimed from Medicare
All States and Territories have cervical screening result registers that help doctors recall women for testing and keep track of any follow-up investigations. For information visit the National Cervical Screening Program.
If high-risk HPV is not detected, the test will be reported as "Negative".
If high-risk HPV is detected, this will be reported and the cytology will be reported separately, as below.
- Negative: non-cancerous cells, but smear may show infection, irritation or normal cell repair.
- Possible low-grade abnormality: minor changes in squamous cells or glandular cells for which the cause is undetermined. Usually repeated in 12 months.
- Low-grade abnormality: changes that may indicate infection with human papilloma virus (HPV). In most cases these will resolve without treatment.
- Possible high-grade abnormality: changes suspicious for, but not diagnostic of, a high-grade abnormality. Referral to a specialist is indicated.
- High-grade abnormality: abnormal cells that may result in cancer if left untreated. Referral to a specialist is indicated.
- Carcinoma: cancer is evident and requires immediate attention.
- Unsatisfactory: inadequate sampling or other problem. Usually repeated in 6-12 weeks
The HPV test is generally used as a screening test. A small percentage of abnormalities in women may go undetected with a single test, which is why it is important to have cervical screening regularly. The most common errors are those made in collecting the sample. The smear represents a very small sample of cells. Even for the most experienced health care provider, sample collection can be occasionally inadequate and a repeat may be required.
The cervical screen, when performed regularly, is a great help in the early detection of cervical cancer, which is treatable if caught at an early stage. Early detection and treatment can prevent 80 to 90 per cent of cancers developing.
If you douche, tub-bathe, or use vaginal creams 48 - 72 hours prior to the examination, your test results might be ‘unsatisfactory’. Other factors that may alter results include mentrual bleeding, infection, drugs (such as digoxin and tetracycline), or having sexual intercourse within 24 hours prior to examination.
In these cases, a repeat screening test may be necessary but does not necessarily mean there is a significant problem. The use of the liquid-based techniques will eliminate most technically unsatisfactory results.